B7-1-transfected tumor vaccine counteracts chemotherapy-induced immunosuppression and prolongs the survival of rats bearing highly metastatic osteosarcoma cells

International Journal of Cancer

Volumn 71, Issue 6, 1997, Pages 1091-1102

  Hayakawa, Mitsuru ^a,b   Kawaguchi, Satoshi ^b   Ishii, Seiichi ^b   Murakami, Masaaki ^a   Uede, Toshimitsu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; HLA B7 ANTIGEN; METHOTREXATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; IMMUNE DEFICIENCY; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG METASTASIS; MALE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIGENS, CD80; ANTIMETABOLITES, ANTINEOPLASTIC; CANCER VACCINES; CELL MEMBRANE; LUNG NEOPLASMS; MALE; METHOTREXATE; MICE; NEOPLASM TRANSPLANTATION; OSTEOSARCOMA; RATS; RATS, INBRED F344; SURVIVAL ANALYSIS; T-LYMPHOCYTES; TRANSFECTION;

EID: 0030941353     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970611)71:6<1091::AID-IJC28>3.0.CO;2-F     Document Type: Article

References (22)

1. AZUMA, M., ITO, D., YAGITA, H., OKUMURA, K., PHILLIPS, J.H., LANIER, L.L. and SOMOZA, C., B70 antigen is a second ligand for CTLA-4 and CD28. Nature (Lond.), 366, 76-79 (1993).
2. + tumor cells are potent vaccines for stimulating tumor rejection in tumor-hearing mice. J. exp. Med., 181, 619-629 (1995).
3. BERD, D., MASTRANGELO, M.J., ENGSTROM, P.E. PAUL, A. and MAGUIRE, H., Augmentation of the human immune response by cyclophosphamide. Cancer Res., 42, 4862-4866 (1982).
4. BERLIN, Ö., SAMID, D., DONTHINENI-RAO, R., AKESON, W., AMIEL, D. and WOODS, V.L., JR., Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice. Cancer Res., 53, 4890-4895 (1993).
5. CHEN, L., ASHE, S., BRADY, W.A., HELLSTRÖM, I., HELLSTRÖM, K.E., LEDBETTER, J.A., MCGOWAN, P. and LINSLEY, P.S., Co-stimulation of antitumor immunity by the B7 counterreceptor for the T-lymphocyte molecules CD28 and CTLA-4. Cell, 71, 1093-1102 (1992).
6. CHEN, L., LINSLEY, P.S. and HELLSTRÖM, K.E., Co-stimulation of T cells for tumor immunity. Immunol. Today, 14, 483-486 (1993).
7. CHEN, L., MCGOWAN, P., ASHE, S., JOHNSTON, J.V., HELLSTRÖM. T. and HELLSTRÖM, K.E., B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum. Cancer Res., 54, 5420-5423 (1994).
8. GLASSER, D.B., LANE, J.M., HUVOS, A.G., MARCOVE, R.C. and ROSEN, G., Survival, prognosis, and therapeutic response in osteogenie sarcoma. Cancer, 69, 698-708 (1992).
9. GOTO, M., MITSUOKA, A., SUGIYAMA, M. and KITANO, M., Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon. J. exp. Med., 154, 204-209 (1981).
10. HAYAKAWA, M., KAWAGUCHI, S., ISHII, S., MURAKAMI, M. and UEDE, T., Establishment of a lung metastaic model by orthotopic implantation of rat osteosarcoma cells. Proceedings of the Japanese Cancer Association, 54th annual meeting, p. 366, Japanese Cancer Association, Tokyo (1995).
11. HODGE, J.W., ABRAMS, S., SCHLOM, J. and KANTOR, J.A., Induction of antitumor immunity by recombinant vaccinia virus expressing B7-1 or B7-2 co-stimulatory molecules. Cancer Res., 54, 5552-5555 (1994).
12. IBAYASHI, Y., UEDE, T., UEDE, T., and KIKUCHI, K., Functional analysis of mononuclear cells infiltrating into tumors: differential cytotoxicity of mononuclear cells from tumors of immune and non-immune rats. J. Immunol., 134, 648-653 (1985).
13. INOBE, M., AOKI, N., LINSLEY, P.S., LEDBETTER, J.A., ABE, R., MURAKAMI, M. and UEDE, T., The role of the B7-1a molecule, an alternatively spliced form of murine B7-1 (CD80), on T-cell activation. J. Immunol., 157, 582-588 (1996).
14. INOBE, M., LINSLEY, P.S., LEDBETTER, J.A., NAGAI, Y., TAMAKOSHI, M. and UEDE, T., Identification of an alternatively spliced form of the murine homologue of B7. Biochem. Biophys. Res. Comm., 200, 443-449 (1994).
15. + T lymphocytes by B7, a natural hgand for CD28, can he used to treat established mouse melanoma J. Immunol., 153, 421-428 (1994).
16. LIN, H., BOLLING, S.F., LINSLEY, P.S., WEI, R.Q., GORDON, D., THOMPSON, C.B. and TURKA, L.A., Long-term acceptance of major histocompatibilitv complex mismatched cardiac allografts induced by CTLA4Ig plus donorspecific transfusion. J. exp. Med., 178, 1801-1806 (1993).
17. MATSUMURA, Y., ZUO, X.J., PREHN, J., LINSLEY, P.S., MARCHEVSKY, A., KASS, R.M., MATLOFF, J.M. and JORDAN, S.C., Soluble CTLA4Ig modifies parameters of acute inflammation in rat lung allograft rejection without altering lymphocyte infiltration or transcription of key cytokines. Transplantation, 59, 551-558 (1995).
18. MATULIONIS, U.A., DOSIOU, C., LAMONT, C., FREEMAN, G.J., MAUCH P., NADLER, L.M. and GRIFFIN, J.D., Role of B7-1 in mediatinG an immune response to myeloid leukemia cells. Blood 85, 2507-2515 (1995).
19. MURAKAMI, M., TAKAHASHI, Y., ISASHI, Y., KON, S., JIA, W-Y., INOBE, M., ABE. R. and UEDE, T., Identification and characterization of an alternative cytotoxic T-lymphocyte-associated proiein 4 binding molecule on B cells. Proc. nat. Acad. Sci. (Wash.), 93, 7838-7842 (1996).
20. TAKAHASHI, K., SATO, K., EGAMI, F., MIYA, T., NARUKAWA, Y. and KANAZAWA, H., Comparison of osteoblastic markers of nine clonal cell lines from rat osteosarcoma cells. J. Bone Min. Metab., 9, 241-247 (1991).
21. TOWNSEND, S.E., SU, F.W., ATHERTON, J.M. and ALLISON, J.P., Specificity and longevity of antirumor immune responses induced bv B7-transfected tumors. Cancer Res., 54, 6477-6483 (1994).
22. VIEWEG, J., ROSENTHAL, F.M., BANNERJI, R., HESTON, W.D.W., FAIR, W.R., GANSBACHER, B. and GILBORE, E., Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene-modified tumor vaccines. Cancer Res., 54, 1760-1765 (1994).